chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient should have received Menactra. Patient contacted the health department and received the Menactra vaccine on 5/13/21.  Patient presented to pharmacy and requested a meningitis vaccine. The Trumenba vaccine was available in the pharmacy and the front if the box indicated it was acceptable for use in individuals from 10-25 years of age.
patient reports feeling itchy on the left arm, red rashes noted at 6:24pm on bilateral upper extremities, Benadryl 25mg administered symptoms resolved
This spontaneous report as received from a nurse, and refers to a patient of unknown age and gender. No pertinent medical history, drug reactions/ allergies or concurrent conditions were reported. On 24-AUG-2018, the patient was vaccinated with a improperly stored VARIVAX (which had a lot # of R002054 and an expiration date of 22-JUN-2020; however, dosage number and route of administration were not reported), for prophylaxis. Nonetheless, no adverse effects were reported. The vaccines experienced the following temperature excursion on an unknown date: 11.3 F for 1 hour and 11 minutes. Reportedly, there had been no previous temperature excusions and the aformentioned ones were identified due to a data logger. Furthermore, no product quality complaint was involved. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1808USA013090:
PT feeling warm, flushed, accelerated pulse, shaking,  No apparent distress Monitor for 30 minutes
cried >3hr p/vax;mom called around 3:30 c/o child crying;pt had fever of 100.0;mom advised to call pvt MD;mom took pt to ER around 6:00;pt had t104;
I got my first moderna shot and two days later i tested positive for covid; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (I got my first moderna shot and two days later i tested positive for covid) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (I got my first moderna shot and two days later i tested positive for covid). At the time of the report, SARS-COV-2 TEST POSITIVE (I got my first moderna shot and two days later i tested positive for covid) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive and negative (Negative) Negative(17 days after COVID positive).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.
10/1/09 Child had reddened area on L lateral thigh about 4-5 inches long, 2-3 inches wide. She had low grade fever (not taken). Calamine lotion was applied and redness dissipated. 10/2/09 about 11 AM reddedned area re-appeared. Mother telephoned health department to report at 4:20PM. Mother wil watch child and if conition doesn't improve or worsens, will take to MD. 10/3/09 TC to mother. Child has recovered without residual redness. Several mosquito bites are also now apparent at same site on L lateral thigh. Afebrile, doing well
Received flu shot (LA) on 10/9/10 - no redness or swelling - pain started that nite and got worse over the next week or so. Then went away & most pain is gone except when he raises his hand or arm. Lifting is painful. Has no doctor or insurance.
muscle pain; This case was reported by a consumer via call center representative and described the occurrence of injection site muscle pain in a 74-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced injection site muscle pain. On an unknown date, the outcome of the injection site muscle pain was unknown.   It was unknown if the reporter considered the injection site muscle pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination may be 73 or 74 years. The patient had muscle pain in the location where he got first Shingrix shot which was two month ago. It was now time for patients second shot and patient was afraid to get that fearing more muscle pain.
Severe hives all over the body but mainly on stomach, and both legs very itchy.  Hives are more severe in the evening.  Treating them with over the counter anti-itch cream.  Currently on day three and today hives were more severe.
Student developed a post rash after her vaccine was given. Was given a shot per EMS and transported to the hospital
Right after vaccine, I experienced with Virginal blood spots NEXT DAY, which is NOT period, weird blood spot, and since that, until NOW, no period.  If that is not the period, I haven't had a period for 2 months, losing 2 cycles. I AM NOT PREGNANT, I AM VERY HEALTHY.
"pt recv vax & 2wk p/vax pt exp stiff neck, pain @ the inj site, & pain in the armpit;"
After extreme muscle soreness and fatigued for a week after vaccination. Nerve pain and numbness on extremities began. Each day is a different location for the nerve pain for example one day it'll be on my left side of my face; the next day will be my hands; the following day will be my left side of my body from underneath my clavicle down my arm and from the side of my leg to my knee, etc. The numbness is felt on the top of my feet occasionally the left side of my face.
severe body aches, fever (102), extreme chills and sweating, severe headache and heart palpitations.
pt recvd vax;07jul95 devel varicella like rash at inject site consisting of 6 lesions;
Developed numbness in arms, hands, feet and legs.  Headaches, irregular periods, heartburn, hives.  Began 2-3 months after first HPV vaccine administered.  Had brain MRI to look for MS with no lesions seen.  10/24/08 Office notes received from PCP. Parent reports continued numbness/tingling of feet/legs/hands, severe headaches and severe heartburn which began 2 months after 1st HPV shot. 12/1/2008 MR received from  neurologist. Referred from PCP for intermittent peripheral neuropathy in variable distribution. Pt presented with a several week hx of intermittant episodes of numbness of the feet, hands, and extremities. Neuro exam normal as pt was asymptomatic at time of exam. Impression:  Paresthesias. F/u reports 3/4/08 with continued numbness all over, interfering with pt's ability to run.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 44 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 13Aug2021 13:15 (Lot number: EW0217) at the age of 44 years as dose 2, single for Covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Product=COVID 19, brand=Pfizer,, Lot number=EW0202,, Lot unknown=False,, Administration time=14:00 PM,, Dose number=1,, vaccine location=Left arm, No events reported.), administration date: 23Jul2021, when the patient was 44 years old, for Covid-19 Immunization. The following information was reported: NIPPLE PAIN (non-serious) with onset 14Aug2021 10:00, outcome "recovering", described as "My right nipple in the center only was sore the day after I had my 2nd shot"; NIPPLE OEDEMA (non-serious) with onset 14Aug2021 10:00, outcome "recovering", described as "Tender to touch and looks a little bigger"; INFLAMMATION (non-serious) with onset 14Aug2021 10:00, outcome "recovering", described as "I read can cause inflammation for up to 4 weeks". Therapeutic measures were not taken as a result of nipple pain, nipple oedema, inflammation. Additional information: Prior to vaccination, patient was not diagnosed with COVID, Since the vaccination, patient has been tested for COVID. No treatment was received, Case assessed as non serious. Follow-Up (07Sep2021): Follow-up attempts are completed. No further information is expected.
Started with a runny nose then turned into a 103+ fever.  Called our pediatrician's after care nurse line on 9/25/2011.
suffered miserably ever since; This case was reported by a consumer and described the occurrence of feeling miserable in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In October 2019, the patient received Shingles vaccine. On an unknown date, less than 2 years after receiving Shingles vaccine, the patient experienced feeling miserable. On an unknown date, the outcome of the feeling miserable was not recovered/not resolved.   It was unknown if the reporter considered the feeling miserable to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient for himself/herself. Age at the vaccination was not reported, however age group was captured as an adult as per vaccine indication. Patient got the shingle shot and had suffered miserably ever since Been to over 10 doctors and had found no relief, had totally taken his/her life away.
I believe some type of clot on my left side of my neck and my right side of my neck; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: THROMBOSIS (medically significant), outcome "unknown", described as "I believe some type of clot on my left side of my neck and my right side of my neck". Clinical course: patient stated, "I'm suffering from. Umm, I believe some type of clot on my left side of my neck and my right side of my neck. I forget the name of the. The vein that's going up through to my brain".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
PATIENT CAME IN OFFICE ON 7/21/2022 AND ON CONSENT FORM STATED PATIENT WAS IN OFFICE FOR 1ST COVID VACCINE. VACCINE WAS GIVEN AND PATIENT WAS SCHDULED FOR 2ND DOSE. PATIENT IN OFFICE 8/11/2022 FOR SECOND DOSE ACCORDING TO CONSENT FORM AND COVID-19 VACCINE CARD THAT WAS GIVEN AT LAST APPOINTMENT. ONCE GIVEN VACCINE AS IT WAS BEING ENTERED INTO DATABASE IS WHEN I NOTICED PATIENT ALREADY HAD TWO DOSE OF THE VACCINE ON 06/2021. WHICH MADE THE VACCINE ON 07/21/2022 THE BOOSTER VACCINE? INFORMED MY SUPERVISIOR AND A PHYSICAN OF THE INCIDIENT AND SPOKE WITH MOTHER AND PATIENT ABOUT THE EXTRA 4TH DOSE AND INFORMED MOTHER OF INCIDENT AS WELL. MOM WAS OKAY AND SEEMED TO NOT HAVE AN ISSUE. MOTHER SEEMED TO HAVE FORGOTTEN PATIENTS SEEMED AS THOUGH MOM FORGOT PATIENT HAD ALREADY GOTTEN TWO DOSES IN JUNE OF 2021. PATIENT WAITED IN OFFICE FOR 15 MIN TO MAKE SURE NO REACTIONS TO INJECTION AND ALSO WAITED AN ADDITIONAL 20 MIN AS I REPORTED INCIDENT. NO ADVERSE REACTIONS NOTED WHILE IN OFFICE.
Information has been received from an LVN concerning a child who in approx. June, 1999, was vaccinated with varicella virus vaccine live. Subsequently, the pt experienced seizure and brain swelling and was hospitalized. A brain biopsy was scheduled to determine course of treatment, therapy and cause. It was reported that the pt's mother was told that the pt's experience was related to therapy with varicella virus vaccine live. Additional information has been requested. Further FU: the physician's office reported that the child was not one of their patients.
jaw pain; facial pain; cough; harder time breathing; out of focus; weekness in leg; fatigue; redness at covid vaccination injections site; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN JAW (jaw pain), FACIAL PAIN (facial pain), COUGH (cough), DYSPNOEA (harder time breathing) and DISTURBANCE IN ATTENTION (out of focus) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product MACITENTAN for Pulmonary hypertension.    Concurrent medical conditions included Pulmonary hypertension. Concomitant products included TREPROSTINIL SODIUM (TYVASO) and TADALAFIL for an unknown indication.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and MACITENTAN (Oral) 10 mg. On an unknown date, the patient experienced PAIN IN JAW (jaw pain), FACIAL PAIN (facial pain), COUGH (cough), DYSPNOEA (harder time breathing), DISTURBANCE IN ATTENTION (out of focus), MUSCULAR WEAKNESS (weekness in leg), FATIGUE (fatigue) and INJECTION SITE ERYTHEMA (redness at covid vaccination injections site). At the time of the report, PAIN IN JAW (jaw pain), FACIAL PAIN (facial pain), COUGH (cough), DYSPNOEA (harder time breathing), DISTURBANCE IN ATTENTION (out of focus), MUSCULAR WEAKNESS (weekness in leg), FATIGUE (fatigue) and INJECTION SITE ERYTHEMA (redness at covid vaccination injections site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication was reported.
8 days after receiving my 3rd booster Pfizer vaccine I developed a severe rash starting under my left breast area which spread to my fingers, arm, stomach, face and back.; started burning then so itchy it was unbearable; started burning then so itchy it was unbearable; other vaccine same date: Flu vaccine; Off-label use; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 51-years-old Non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: FF2590), third dose via an unspecified route of administration, administered in Arm Left on 13Oct2021 12:00 (At the age of 51 year) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation and on same day patient also took influenza vaccine (FLU VACCINE VII), via an unspecified route of administration from 13Oct2021 (Batch/Lot number was not reported) to 13Oct2021, at DOSE 1, SINGLE for immunization. Medical history included hypertension (other medical history: high blood pressure), asthma (other medical history: Asthma) from an unknown date and unknown if ongoing. There were no concomitant medications. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0150), second dose via an unspecified route of administration, administered in Arm Left on 07Apr2021 16:00 (At the age of 51 year) as dose 2 single and bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6205), first dose via an unspecified route of administration, administered in Arm Left on 17Mar2021 16:00 (At the age of 51 year) as dose 1 single for covid-19 immunization. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior vaccination and since the vaccination. Patient experienced eight days after receiving my third booster Pfizer vaccine and developed a severe rash starting under my left breast area which spread to my fingers, arm, stomach, face and back. First started burning then so itchy it was unbearable. Had to see a doctor twice and was put on prednisone to help relieve my itching & spreading. Just started the first dose of antibiotics today seems to be helping. she knew it is the vaccine since she did nothing else out of the ordinary prior to this outbreak. The adverse event resulted in doctor or other healthcare professional office/clinic visit. While treatment received for the adverse events was Prednisone and ketoconazole. Case was considered as non-serious. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
presents to the ED with Chief Complaint: CHEST PAIN. It is described as pressure and it is described as located in the central chest area. This started 0500. No nausea, vomiting or diaphoresis. Patient states he awoke in morning with feeling that he had palpitations as well as central subtle chest pressure. He has had difficulty breathing and state CP seems to be worse with deep breath.    IN ED Vitals were ( Temp: 98.8 F. BP: 150/98. MAP: 115. HR: 166. O2 saturation: 85% on RA) and Initial HR was concerning for A-Fib with RVR, HR 166, was given IV Dilt 20 mg IV with excellent response and F/U HR was in 80s and was transitioned to PO Dilt (30 mg Q8) and was started on new anticoagulation for a-fib.
Symptoms started 10/24 - numbness/tingling of fingers and toes. 10/25 generalized numbness and difficulty walking -> went to ED. ED BP 200/100. Neuro ->10/27 diffuse reduction in reflex on lower extremities. SOB and difficulty swallowing tx: cycle of plasmapheresis and IVIG therapy. Transferred to rehab on 11/15.
COVID 19; COVID 19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Apr2021 as dose 1, single (Batch/Lot number: unknown), in left arm and on 05May2021 as dose 2, single (Batch/Lot number: unknown) at the age of 29 years, in left arm for COVID-19 immunization. The patient's relevant medical history included: "dose 1, 2 - Pfizer/ dose 3 - moderna" (unspecified if ongoing), notes: dose 1, 2 - Pfizer/ dose 3 - moderna. The patient's concomitant medications were not reported. The following information was reported: SUSPECTED COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19". Therapeutic measures were taken as a result of suspected covid-19, drug ineffective. Clinical course: Patient had a horrendous taste in her mouth throughout treatment, some combo of citric acid and metallic that made it hard to sleep it was so awful. About 4 days after treatment stopped some of her symptoms were returned. About 4 days after treatment stopped some of my symptoms returned. She had a fever again, a cough, a stuffy nose, fatigue, muscle aches, and her tests were coming back strongly positive. Frankly had she known about either of these things she never would have taken Paxlovid. Treatment of COVID-19 started on 04May2022 and date of last administration: 09May2022 (Paxlovid).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sore throat; Strep Throat Confirmed by Throat Swab; This spontaneous case was reported by a nurse and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat) and PHARYNGITIS STREPTOCOCCAL (Strep Throat Confirmed by Throat Swab) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat) and PHARYNGITIS STREPTOCOCCAL (Strep Throat Confirmed by Throat Swab). At the time of the report, OROPHARYNGEAL PAIN (Sore throat) and PHARYNGITIS STREPTOCOCCAL (Strep Throat Confirmed by Throat Swab) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Apr-2021, Culture throat: (abnormal) Strep Throat.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medication was reported.  Treatment information was not provided. Action taken with mRNA-1273 in response to the event was unknown
Lots of swelling/bruising/hardening at injection site. Started to improve 11/20/12.
Vaccines experienced TE and then administered to a patient with no reports of side effects.; Vaccines experienced TE and then administered to a patient with no reports of side effects.; This spontaneous report was received from a medical assistant, referring to a patient of unspecified age and gender.   The patient's concurrent conditions, medical history, previous drug reactions, drug allergies and concomitant therapies were not reported.  On 24-JUL-2023, the patient was vaccinated with an improperly stored doses of hepatitis a vaccine, inactivated (VAQTA) (involved lot # was X004814, expiration date: 10-OCT-2024); with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) recombinant Human albumin (rHa) (involved lot # was X012186, expiration date: 19-JUL-2024); and with varicella virus vaccine live (oka/merck) (VARIVAX) (involved lot # was X007372, expiration date: 12-MAR-2025) all administered for prophylaxis (strength, route, and site of administration were not provided). Temperature excursion and time frame were not specified by the reporter, and there was no report of side effects, nor product quality complaint was involved.   This is one of two reports from the same reporter.  ; Sender's Comments:  US-009507513-2307USA011441:
I noticed a rash on my leg on 11APR2023 and then the next day it was considerably worse so I went to Hospital and saw Dr. and he diagnosed Vasculitis and sent me home saying to go see my PCP and a Dermatologist. I saw Dr. on13-APR-2023 and Dr. a Dermatologist on 19-APR-2023 all confirming Vasculitis.
Initial report was received from a health care professional on 19 January 2012. This case is one of a cluster of seven patients reported by the same reporter who each experienced adverse events following administration of FLUZONE (lot number not reported). The events for the other patients were captured in case numbers 2012-00770, 2012-00771, 2012-00772, 2012-00774, 2012-00775 and 2012-00776. A 41-year-old female patient had received an injection of FLUZONE, sanofi pasteur Inc. (lot number, route and site of administration unknown) on 04 October 2011. Following vaccination the patient reported right shoulder pain, right axilla tenderness and swelling which persisted from 04 October 2011 to 23 November 2011. The patient also had a low grade fever off and on until November. It was unknown if the patient had any illness at the time of vaccination, had any pre-existing medical conditions, took any concomitant medications or had any other vaccinations within 4 weeks of FLUZONE. The patient had previous "arm issues" due to prior reaction to anesthesia. No further information was available at the time of the report. The patient's outcome was unknown. Documents held by sender: none.
Pt daughter informed me yesterday that pt had severe rxn to imz.  Fever 108, pain all over body, and palpitations.  She had to be taken to hospital by ambulance but has since been released and is feeling better.
Information regarding Flumist was received from a healthcare professional regarding a 6 year old male pt who experienced sinus symptoms and a stiff neck. At 6 years of age, the pt received a dose on 12/10/03. The pt developed sinus symptoms and a stiff neck during the night on 12/10/03. The reporter noted that the physician did not feel that the events were related to Flumist. No additional info was available at the date of this report.
Headaches daily, swollen lymph and neck, loss of appetite, nausea, tender belly. Blood tests reveal nothing. Chiropractic and lymph massage provides temporary relief. Can't afford neuro feedback treatment.